Dr Reddys Laboratories has recorded 24% growth in revenues in Russia / CIS region to US$ 150 million in the eleven months ended February 2009. This is based on invoicing as per average foreign currency rates for this period, excluding any impact due to cash flow hedging. In the process, Dr Reddys has become the largest Indian pharmaceutical company in Russia, and is also boasting of as the fastest growing International branded generic company by volume.
As per Russian Market research firm Pharmexpert, Dr Reddys is ranked 7th amongst generic companies in Russia as of February 2009. Dr Reddys top four brands in Russian Market are Omez, Nisa, Ketorol, Cirpolet and Pharmexpert has ranked them as No. 1 in their respective molecular segment. crackcrack